TrialThe Lancet. Infectious diseases2016

Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial.

Evelien de Jong et al.PubMed ↗Publisher ↗

No numbers read from the abstract.